000300316 001__ 300316
000300316 005__ 20250624150321.0
000300316 0247_ $$2doi$$a10.1007/s00761-025-01692-6
000300316 0247_ $$2ISSN$$a2731-7226
000300316 0247_ $$2ISSN$$a0947-8965
000300316 0247_ $$2ISSN$$a1433-0415
000300316 0247_ $$2ISSN$$a2731-7234
000300316 037__ $$aDKFZ-2025-00762
000300316 041__ $$aGerman
000300316 082__ $$a610
000300316 1001_ $$aWagner, A. S.$$b0
000300316 245__ $$aLiving with cancer-related fatigue.[Leben mit krebsassoziierter Fatigue.] [Die Perspektive der Betroffenen und involvierter Fachpersonen].The perspective of those affected and professionals involved.
000300316 260__ $$aNew York$$bSpringer Medizin$$c2025
000300316 3367_ $$2DRIVER$$aarticle
000300316 3367_ $$2DataCite$$aOutput Types/Journal article
000300316 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1750770074_16805
000300316 3367_ $$2BibTeX$$aARTICLE
000300316 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300316 3367_ $$00$$2EndNote$$aJournal Article
000300316 500__ $$aVolume 31, pages 708–713, (2025)
000300316 520__ $$aBackground: As survival rates increase, the care of physical and psychological consequences of cancer and cancer therapies is becoming increasingly urgent. Even if cancer-related fatigue (CRF) is one of the most common sequelae, it has so far been inadequately treated. Objectives: To record the impairments experienced by patients due to CRF in Germany and to reflect the perspectives of various specialist groups on this. Materials and methods: Within the large-scaled LIFT (Longitudinal Investigation of Cancer-related Fatigue and its Treatment) project, we conducted surveys among patients (N = 1179), as well as among physicians (N = 148), nurses (N = 184), and psycho-oncologists (N = 144). Among others, participants were asked to describe health-related quality of life in terms of CRF. Data were analyzed descriptively. Results: Among patients, there was a significant negative association between the perceived quality of life and CRF severity (r = -0.556, p < 0.001). More than half of the physicians (65.5%), nurses (70.7%), and psycho-oncologists (64.6%) estimated the impact of CRF on quality of life to be very high, but generally estimated by professionals to be slightly less than the impact of pain on quality of life. Conclusion: Physicians, nurses, and psycho-oncologists appeared to be aware of the influence of CRF on the quality of life of patients. However, CRF-management programs are needed across the board in Germany.
000300316 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000300316 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000300316 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b1$$udkfz
000300316 7001_ $$0P:(DE-He78)2c984a7f2206879886962a4375764178$$aBlickle, Patricia$$b2$$udkfz
000300316 7001_ $$aJentschke, E.$$b3
000300316 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b4$$udkfz
000300316 7001_ $$aMaatouk, Imad$$b5
000300316 773__ $$0PERI:(DE-600)3120761-3$$a10.1007/s00761-025-01692-6$$p708–713$$tDie Onkologie$$v31$$x2731-7226$$y2025
000300316 909CO $$ooai:inrepo02.dkfz.de:300316$$pVDB
000300316 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000300316 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2c984a7f2206879886962a4375764178$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300316 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000300316 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000300316 9141_ $$y2025
000300316 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-11$$wger
000300316 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-11$$wger
000300316 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONKOLOGIE-GER : 2022$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000300316 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-11
000300316 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Krebsprävention und Survivorship$$x0
000300316 980__ $$ajournal
000300316 980__ $$aVDB
000300316 980__ $$aI:(DE-He78)C110-20160331
000300316 980__ $$aUNRESTRICTED